可手术治疗的慢性血栓栓塞性肺动脉高压患者的吸气量无变化。
Inspiratory capacity is not altered in operable chronic thromboembolic pulmonary hypertension.
作者信息
Richter Manuel J, Gall Henning, Wittkämper Gesa, Seeger Werner, Mayer Eckhard, Ghofrani Hossein A, Guth Stefan, Reichenberger Frank
机构信息
1 Department of Pneumology, Kerckhoff Heart, Rheuma and Thoracic Center, Bad Nauheim, Germany.
2 Department of Internal Medicine, Justus-Liebig-University Giessen, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Giessen, Germany.
出版信息
Pulm Circ. 2017 Apr-Jun;7(2):543-546. doi: 10.1177/2045893217709763. Epub 2017 May 12.
Abstract
Pathological alterations of inspiratory capacity (IC) have been observed in pulmonary hypertension. However, the clinical significance of IC in operable chronic thromboembolic pulmonary hypertension (CTEPH) without other pulmonary diseases remains unknown. CTEPH patients scheduled for pulmonary endarterectomy were prospectively screened. Despite being associated with functional capacity, pathological alterations of IC were not observed.
摘要
在肺动脉高压中已观察到吸气容量（IC）的病理改变。然而，IC在无其他肺部疾病的可手术慢性血栓栓塞性肺动脉高压（CTEPH）中的临床意义仍不清楚。对计划进行肺动脉内膜剥脱术的CTEPH患者进行了前瞻性筛查。尽管IC与功能能力相关，但未观察到IC的病理改变。
相似文献
1
Inspiratory capacity is not altered in operable chronic thromboembolic pulmonary hypertension.可手术治疗的慢性血栓栓塞性肺动脉高压患者的吸气量无变化。
Pulm Circ. 2017 Apr-Jun;7(2):543-546. doi: 10.1177/2045893217709763. Epub 2017 May 12.
2
Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry.慢性血栓栓塞性肺动脉高压（CTEPH）：来自国际前瞻性登记研究的结果。
Circulation. 2011 Nov 1;124(18):1973-81. doi: 10.1161/CIRCULATIONAHA.110.015008. Epub 2011 Oct 3.
3
Chronic thromboembolic pulmonary hypertension: role of medical therapy.慢性血栓栓塞性肺动脉高压：药物治疗的作用。
Eur Respir J. 2013 Apr;41(4):985-90. doi: 10.1183/09031936.00201612. Epub 2013 Feb 8.
4
Operability assessment in CTEPH: Lessons from the CHEST-1 study.CTEPH 中的可操作性评估：来自 CHEST-1 研究的经验教训。
J Thorac Cardiovasc Surg. 2016 Sep;152(3):669-674.e3. doi: 10.1016/j.jtcvs.2016.02.062. Epub 2016 Mar 10.
5
Exercise physiological responses to drug treatments in chronic thromboembolic pulmonary hypertension.慢性血栓栓塞性肺动脉高压中运动对药物治疗的生理反应
J Appl Physiol (1985). 2016 Sep 1;121(3):623-8. doi: 10.1152/japplphysiol.00087.2016. Epub 2016 Jul 14.
6
Chronic thromboembolic pulmonary hypertension: evolution in management.慢性血栓栓塞性肺动脉高压：治疗进展
Curr Opin Pulm Med. 2014 Sep;20(5):400-8. doi: 10.1097/MCP.0000000000000088.
7
Treatment of chronic thromboembolic pulmonary hypertension in a multidisciplinary team.多学科团队治疗慢性血栓栓塞性肺动脉高压。
Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619891529. doi: 10.1177/1753466619891529.
8
Epidemiology and management of chronic thromboembolic pulmonary hypertension: experience from two expert centers.慢性血栓栓塞性肺动脉高压的流行病学和管理：来自两个专家中心的经验。
Hellenic J Cardiol. 2018 Jan-Feb;59(1):16-23. doi: 10.1016/j.hjc.2017.05.005. Epub 2017 May 17.
9
Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.波生坦治疗无法手术的慢性血栓栓塞性肺动脉高压：BENEFiT（波生坦对无法手术的慢性血栓栓塞性肺动脉高压形式的影响），一项随机、安慰剂对照试验。
J Am Coll Cardiol. 2008 Dec 16;52(25):2127-34. doi: 10.1016/j.jacc.2008.08.059.
10
Balloon pulmonary angioplasty: an additional treatment option to improve the prognosis of patients with chronic thromboembolic pulmonary hypertension.球囊肺动脉成形术：改善慢性血栓栓塞性肺动脉高压患者预后的另一种治疗选择。
EuroIntervention. 2014 Aug;10(4):518-25. doi: 10.4244/EIJV10I4A89.
引用本文的文献
1
Pulmonary Vascular Disease and Cardiopulmonary Exercise Testing.肺血管疾病与心肺运动试验
Front Physiol. 2020 Aug 5;11:964. doi: 10.3389/fphys.2020.00964. eCollection 2020.
本文引用的文献
1
Hemodynamic and ventilatory responses during exercise in chronic thromboembolic disease.慢性血栓栓塞性疾病患者运动期间的血液动力学和通气反应。
J Thorac Cardiovasc Surg. 2016 Sep;152(3):763-71. doi: 10.1016/j.jtcvs.2016.05.058. Epub 2016 Jun 5.
2
Reduced force of diaphragm muscle fibers in patients with chronic thromboembolic pulmonary hypertension.慢性血栓栓塞性肺动脉高压患者膈肌肌纤维力量减弱。
Am J Physiol Lung Cell Mol Physiol. 2016 Jul 1;311(1):L20-8. doi: 10.1152/ajplung.00113.2016. Epub 2016 May 17.
3
Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort.肺动脉内膜剥脱术后患者长期预后的动态风险分层：来自英国全国队列的结果
Circulation. 2016 May 3;133(18):1761-71. doi: 10.1161/CIRCULATIONAHA.115.019470. Epub 2016 Apr 6.
4
Inspiratory muscle function, dynamic hyperinflation and exertional dyspnoea in pulmonary arterial hypertension.肺动脉高压患者的吸气肌功能、动态肺过度充气与运动性呼吸困难
Eur Respir J. 2015 May;45(5):1495-8. doi: 10.1183/09031936.00153214.
5
Outcome of pulmonary endarterectomy in symptomatic chronic thromboembolic disease.症状性慢性血栓栓塞性疾病肺血管内膜切除术的结果。
Eur Respir J. 2014 Dec;44(6):1635-45. doi: 10.1183/09031936.00050114. Epub 2014 Sep 18.
6
The prognostic significance of inspiratory capacity in pulmonary arterial hypertension.吸气容量在肺动脉高压中的预后意义。
Respiration. 2014;88(1):24-30. doi: 10.1159/000360481. Epub 2014 May 21.
7
The combination of exercise and respiratory training improves respiratory muscle function in pulmonary hypertension.运动与呼吸训练相结合可改善肺动脉高压患者的呼吸肌功能。
Lung. 2014 Apr;192(2):321-8. doi: 10.1007/s00408-013-9542-9. Epub 2013 Dec 13.
8
Inefficient exercise gas exchange identifies pulmonary hypertension in chronic thromboembolic obstruction following pulmonary embolism.运动气体交换效率低下可识别出肺栓塞后慢性血栓栓塞性梗阻中的肺动脉高压。
Thromb Res. 2013;132(6):659-65. doi: 10.1016/j.thromres.2013.09.032. Epub 2013 Sep 27.
9
Dynamic respiratory mechanics and exertional dyspnoea in pulmonary arterial hypertension.动态呼吸力学与肺动脉高压运动性呼吸困难。
Eur Respir J. 2013 Mar;41(3):578-87. doi: 10.1183/09031936.00223611. Epub 2012 Jul 12.
10
Does dynamic hyperinflation contribute to dyspnoea during exercise in patients with COPD?动态过度充气是否会导致 COPD 患者运动时呼吸困难？
Eur Respir J. 2012 Aug;40(2):322-9. doi: 10.1183/09031936.00157711. Epub 2011 Dec 19.
Zotero 插件